Cell senescence: basic mechanisms and the need for computational networks in vascular ageing.

This review seeks to provide an update of the mechanisms of vascular cell senescence, from newly identified molecules to arterial ageing phenotypes, and finally to present a computational approach to connect these selected proteins in biological networks. We will discuss current key signalling and gene expression pathways by which these focus proteins and networks drive normal and accelerated vascular ageing. We also review the possibility that senolytic drugs, designed to restore normal cell differentiation and function, could effectively treat multiple age-related vascular diseases. Finally, we discuss how cell senescence is both a cause and a consequence of vascular ageing because of the possible feedback controls between identified networks.

[1]  M. Serrano,et al.  Galacto‐conjugation of Navitoclax as an efficient strategy to increase senolytic specificity and reduce platelet toxicity , 2020, Aging cell.

[2]  Z. Ju,et al.  Telomere dysfunction promotes small vessel vasculitis via the LL37-NETs-dependent mechanism , 2020, Annals of translational medicine.

[3]  Farzaneh A. Sorond,et al.  Mechanisms of Vascular Aging, A Geroscience Perspective: JACC Focus Seminar. , 2020, Journal of the American College of Cardiology.

[4]  M. Siedlinski,et al.  T-Cell–Derived miRNA-214 Mediates Perivascular Fibrosis in Hypertension , 2020, Circulation research.

[5]  J. Fuster,et al.  Clonal hematopoiesis driven by somatic mutations: A new player in atherosclerotic cardiovascular disease. , 2020, Atherosclerosis.

[6]  J. Michel Phylogenic determinants of cardiovascular frailty, focus on hemodynamics and arterial smooth muscle cells. , 2020, Physiological reviews.

[7]  B. A. David,et al.  Macrophage galactose lectin is critical for Kupffer cells to clear aged platelets , 2020, The Journal of experimental medicine.

[8]  J. Fish,et al.  Cellular senescence contributes to age‐dependent changes in circulating extracellular vesicle cargo and function , 2020, Aging cell.

[9]  S. Laurent,et al.  Mechanisms of Arterial Stiffening , 2019, Arteriosclerosis, thrombosis, and vascular biology.

[10]  F. Forouzandeh,et al.  SQSTM1/p62 and PPARGC1A/PGC-1alpha at the interface of autophagy and vascular senescence , 2020, Autophagy.

[11]  A. Zeiher,et al.  Clonal hematopoiesis, aging and cardiovascular diseases. , 2019, Experimental hematology.

[12]  R. de Cabo,et al.  Effects of Intermittent Fasting on Health, Aging, and Disease. , 2019, The New England journal of medicine.

[13]  T. Ago,et al.  Attenuation of Angiotensin II–Induced Hypertension in BubR1 Low‐Expression Mice Via Repression of Angiotensin II Receptor 1 Overexpression , 2019, Journal of the American Heart Association.

[14]  Hu Li,et al.  BubR1 allelic effects drive phenotypic heterogeneity in mosaic-variegated aneuploidy progeria syndrome. , 2019, The Journal of clinical investigation.

[15]  B. Ebert,et al.  Clonal hematopoiesis in human aging and disease , 2019, Science.

[16]  Ling-Qing Yuan,et al.  Adipose tissue-derived omentin-1 attenuates arterial calcification via AMPK/Akt signaling pathway , 2019, Aging.

[17]  C. Schmitt,et al.  Cellular Senescence: Defining a Path Forward , 2019, Cell.

[18]  V. Gudnason,et al.  HDAC9 is implicated in atherosclerotic aortic calcification and affects vascular smooth muscle cell phenotype , 2019, Nature Genetics.

[19]  Yuanhong Xu,et al.  The synergistic action of phosphate and interleukin-6 enhances senescence-associated calcification in vascular smooth muscle cells depending on p53 , 2019, Mechanisms of Ageing and Development.

[20]  A. Jaeschke,et al.  ApoER2 (Apolipoprotein E Receptor-2) Deficiency Accelerates Smooth Muscle Cell Senescence via Cytokinesis Impairment and Promotes Fibrotic Neointima After Vascular Injury. , 2019, Arteriosclerosis, thrombosis, and vascular biology.

[21]  M. Runge,et al.  Increased mitochondrial NADPH oxidase 4 (NOX4) expression in aging is a causative factor in aortic stiffening , 2019, Redox biology.

[22]  P. Kapahi,et al.  From discoveries in ageing research to therapeutics for healthy ageing , 2019, Nature.

[23]  J. Ge,et al.  Aldehyde dehydrogenase 2 deficiency promotes atherosclerotic plaque instability through accelerating mitochondrial ROS-mediated vascular smooth muscle cell senescence. , 2019, Biochimica et biophysica acta. Molecular basis of disease.

[24]  Hua-Lin Wu,et al.  Shear-Induced CCN1 Promotes Atheroprone Endothelial Phenotypes and Atherosclerosis. , 2019, Circulation.

[25]  D. Baker,et al.  Pak2 kinase promotes cellular senescence and organismal aging , 2019, Proceedings of the National Academy of Sciences.

[26]  P. Nilsson,et al.  Concept of Extremes in Vascular Aging. , 2019, Hypertension.

[27]  P. Li,et al.  Long noncoding RNA MEG3 prevents vascular endothelial cell senescence by impairing miR-128-dependent Girdin downregulation. , 2019, American journal of physiology. Cell physiology.

[28]  Y. Liao,et al.  LncRNA H19 promotes vascular inflammation and abdominal aortic aneurysm formation by functioning as a competing endogenous RNA. , 2019, Journal of molecular and cellular cardiology.

[29]  Xinhua Liu,et al.  Fra‐1 plays a critical role in angiotensin II—induced vascular senescence , 2019, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[30]  Ira Tabas,et al.  Inflammation and its resolution in atherosclerosis: mediators and therapeutic opportunities , 2019, Nature Reviews Cardiology.

[31]  T. Yarovinsky,et al.  Platelet-derived miR-223 promotes a phenotypic switch in arterial injury repair , 2019, Journal of Clinical Investigation.

[32]  P. Massion,et al.  Tobacco smoking induces cardiovascular mitochondrial oxidative stress, promotes endothelial dysfunction, and enhances hypertension. , 2019, American journal of physiology. Heart and circulatory physiology.

[33]  P. Mastroberardino,et al.  Metabolic Alterations in Aging Macrophages: Ingredients for Inflammaging? , 2019, Trends in immunology.

[34]  F. Jaffer,et al.  HDAC9 complex inhibition improves smooth muscle-dependent stenotic vascular disease. , 2019, JCI insight.

[35]  M. Daemen,et al.  Identifying the anti-inflammatory response to lipid lowering therapy: a position paper from the working group on atherosclerosis and vascular biology of the European Society of Cardiology. , 2018, Cardiovascular research.

[36]  Xianying Huang,et al.  miR-21 regulates vascular smooth muscle cell function in arteriosclerosis obliterans of lower extremities through AKT and ERK1/2 pathways , 2018, Archives of medical science : AMS.

[37]  A. Donato,et al.  The role of senescence, telomere dysfunction and shelterin in vascular aging , 2018, Microcirculation.

[38]  Yuhuang Li,et al.  Long non-coding RNA H19 regulates endothelial cell aging via inhibition of STAT3 signalling , 2018, Cardiovascular research.

[39]  M. Bennett,et al.  Molecular insights into vascular aging , 2018, Aging.

[40]  P. Tsao,et al.  H19 Induces Abdominal Aortic Aneurysm Development and Progression , 2018, Circulation.

[41]  S. Tarantini,et al.  Mechanisms of Vascular Aging. , 2018, Circulation research.

[42]  Qilong Wang,et al.  β-Hydroxybutyrate Prevents Vascular Senescence through hnRNP A1-Mediated Upregulation of Oct4. , 2018, Molecular cell.

[43]  M. Capogrossi,et al.  miR-34a Promotes Vascular Smooth Muscle Cell Calcification by Downregulating SIRT1 (Sirtuin 1) and Axl (AXL Receptor Tyrosine Kinase) , 2018, Arteriosclerosis, thrombosis, and vascular biology.

[44]  J. Gettemans,et al.  Intracellular displacement of p53 using transactivation domain (p53 TAD) specific nanobodies , 2018, mAbs.

[45]  T. Finkel,et al.  The role of mitochondria in aging , 2018, The Journal of clinical investigation.

[46]  P. Robbins,et al.  Nuclear Genomic Instability and Aging. , 2018, Annual review of biochemistry.

[47]  M. Bennett,et al.  Defective Base Excision Repair of Oxidative DNA Damage in Vascular Smooth Muscle Cells Promotes Atherosclerosis , 2018, Circulation.

[48]  M. Demaria,et al.  Hallmarks of Cellular Senescence. , 2018, Trends in cell biology.

[49]  P. Guns,et al.  Neuregulin-1 attenuates stress-induced vascular senescence , 2018, Cardiovascular research.

[50]  A. Waisman,et al.  Interleukin-1β promotes atheroprotective changes of advanced atherosclerotic lesions in mice , 2018, Nature Medicine.

[51]  D. Allison,et al.  Senolytics Improve Physical Function and Increase Lifespan in Old Age , 2018, Nature Medicine.

[52]  M. Bennett,et al.  Restoring mitochondrial DNA copy number preserves mitochondrial function and delays vascular aging in mice , 2018, Aging cell.

[53]  N. Mizushima A brief history of autophagy from cell biology to physiology and disease , 2018, Nature Cell Biology.

[54]  Hu Li,et al.  Senescent cells: a therapeutic target for cardiovascular disease , 2018, The Journal of clinical investigation.

[55]  A. Avolio,et al.  Smooth muscle cell and arterial aging: basic and clinical aspects , 2018, Cardiovascular research.

[56]  M. Bennett,et al.  Vascular smooth muscle cell death, autophagy and senescence in atherosclerosis , 2018, Cardiovascular research.

[57]  S. Allahverdian,et al.  Smooth muscle cell fate and plasticity in atherosclerosis , 2018, Cardiovascular research.

[58]  A. Durham,et al.  Role of smooth muscle cells in vascular calcification: implications in atherosclerosis and arterial stiffness , 2018, Cardiovascular research.

[59]  Yaeni Kim,et al.  The protective effect of resveratrol on vascular aging by modulation of the renin-angiotensin system. , 2018, Atherosclerosis.

[60]  J. Montani,et al.  Arginase-II activates mTORC1 through myosin-1b in vascular cell senescence and apoptosis , 2018, Cell Death & Disease.

[61]  G. Weinbauer,et al.  Safety testing of monoclonal antibodies in non-human primates: Case studies highlighting their impact on human risk assessment , 2018, mAbs.

[62]  A. Aviv,et al.  Short Leukocyte Telomere Length Precedes Clinical Expression of Atherosclerosis , 2017, Circulation research.

[63]  K. Yuan,et al.  Downregulation of Pin1 in human atherosclerosis and its association with vascular smooth muscle cell senescence , 2017, Journal of vascular surgery.

[64]  K. Costa,et al.  Rho Kinase Regulates Aortic Vascular Smooth Muscle Cell Stiffness Via Actin/SRF/Myocardin in Hypertension , 2017, Cellular Physiology and Biochemistry.

[65]  S. Laurent,et al.  Vascular Smooth Muscle Cells and Arterial Stiffening: Relevance in Development, Aging, and Disease. , 2017, Physiological reviews.

[66]  L. Zambonin,et al.  Glycosides from Stevia rebaudiana Bertoni Possess Insulin-Mimetic and Antioxidant Activities in Rat Cardiac Fibroblasts , 2017, Oxidative medicine and cellular longevity.

[67]  J. Marth,et al.  Sialylation on O-glycans protects platelets from clearance by liver Kupffer cells , 2017, Proceedings of the National Academy of Sciences.

[68]  K. Griendling,et al.  Zinc regulates Nox1 expression through a NF‐&kgr;B and mitochondrial ROS dependent mechanism to induce senescence of vascular smooth muscle cells , 2017, Free radical biology & medicine.

[69]  F. Cao,et al.  Moderate Autophagy Inhibits Vascular Smooth Muscle Cell Senescence to Stabilize Progressed Atherosclerotic Plaque via the mTORC1/ULK1/ATG13 Signal Pathway , 2017, Oxidative medicine and cellular longevity.

[70]  Athanase Benetos,et al.  Ancestry, Telomere Length, and Atherosclerosis Risk , 2017, Circulation. Cardiovascular genetics.

[71]  M. Ushio-Fukai,et al.  ROS-induced ROS release orchestrated by Nox4, Nox2, and mitochondria in VEGF signaling and angiogenesis. , 2017, American journal of physiology. Cell physiology.

[72]  Francesco Paneni,et al.  The Aging Cardiovascular System: Understanding It at the Cellular and Clinical Levels. , 2017, Journal of the American College of Cardiology.

[73]  Wiggert A. van Cappellen,et al.  Targeted Apoptosis of Senescent Cells Restores Tissue Homeostasis in Response to Chemotoxicity and Aging , 2017, Cell.

[74]  M. Bennett,et al.  Killing the old: cell senescence in atherosclerosis , 2017, Nature Reviews Cardiology.

[75]  Laura S. Shankman,et al.  Activation of the ESC pluripotency factor OCT4 in smooth muscle cells is atheroprotective , 2016, Nature Medicine.

[76]  S. Vatner,et al.  Extracellular Matrix Disarray as a Mechanism for Greater Abdominal Versus Thoracic Aortic Stiffness With Aging in Primates , 2016, Arteriosclerosis, thrombosis, and vascular biology.

[77]  M. Bennett,et al.  Vascular Smooth Muscle Cells in Atherosclerosis. , 2016, Circulation research.

[78]  M. Bennett,et al.  DNA Damage and Repair in Vascular Disease. , 2016, Annual review of physiology.

[79]  Stéphane Laurent,et al.  Central Artery Stiffness in Hypertension and Aging: A Problem With Cause and Consequence. , 2016, Circulation research.

[80]  Youichi Kobayashi,et al.  Counteractive effects of omentin-1 against atherogenesis†. , 2016, Cardiovascular research.

[81]  G. Owens,et al.  Epigenetic Control of Smooth Muscle Cell Identity and Lineage Memory. , 2015, Arteriosclerosis, thrombosis, and vascular biology.

[82]  A. Raucci,et al.  MicroRNA-34a Induces Vascular Smooth Muscle Cells Senescence by SIRT1 Downregulation and Promotes the Expression of Age-Associated Pro-inflammatory Secretory Factors. , 2015, The journals of gerontology. Series A, Biological sciences and medical sciences.

[83]  K. Hoeflich,et al.  p21-Activated Kinase 2 Regulates Endothelial Development and Function through the Bmk1/Erk5 Pathway , 2015, Molecular and Cellular Biology.

[84]  P. Nelson,et al.  MTOR regulates the pro-tumorigenic senescence-associated secretory phenotype by promoting IL1A translation , 2015, Nature Cell Biology.

[85]  N. Sharpless,et al.  Forging a signature of in vivo senescence , 2015, Nature Reviews Cancer.

[86]  P. Lu,et al.  Landscape of Pin1 in the cell cycle , 2015, Experimental biology and medicine.

[87]  Zhongkui Hong,et al.  Augmented Vascular Smooth Muscle Cell Stiffness and Adhesion When Hypertension Is Superimposed on Aging , 2015, Hypertension.

[88]  Y. Maehara,et al.  BubR1 Insufficiency Inhibits Neointimal Hyperplasia Through Impaired Vascular Smooth Muscle Cell Proliferation in Mice , 2015, Arteriosclerosis, thrombosis, and vascular biology.

[89]  M. Grootaert,et al.  Autophagy in Vascular Disease , 2015, Circulation research.

[90]  J. Campisi,et al.  Senescence and apoptosis: dueling or complementary cell fates? , 2014, EMBO reports.

[91]  A. M. Thompson,et al.  CALL FOR PAPERS Cardiovascular and Cerebrovascular Aging—New Mechanisms and Insights Age-related loss of SirT1 expression results in dysregulated human vascular smooth muscle cell function , 2014 .

[92]  Soyoung Lee,et al.  Synthetic lethal metabolic targeting of cellular senescence in cancer therapy , 2013, Nature.

[93]  R. Alexander,et al.  Peroxisome Proliferator-Activated Receptor &ggr; Coactivator-1&agr; Is a Central Negative Regulator of Vascular Senescence , 2013, Arteriosclerosis, thrombosis, and vascular biology.

[94]  Robert J. Saphirstein,et al.  The Focal Adhesion: A Regulated Component of Aortic Stiffness , 2013, PloS one.

[95]  J. Campisi,et al.  Cellular senescence and the senescent secretory phenotype: therapeutic opportunities. , 2013, The Journal of clinical investigation.

[96]  David A. Gewirtz,et al.  Autophagy and senescence , 2013, Autophagy.

[97]  A. Akhmedov,et al.  Deletion of the Activated Protein-1 Transcription Factor JunD Induces Oxidative Stress and Accelerates Age-Related Endothelial Dysfunction , 2013, Circulation.

[98]  T. Lehtimäki,et al.  Smooth muscle cells in human atherosclerosis: proteomic profiling reveals differences in expression of Annexin A1 and mitochondrial proteins in carotid disease. , 2013, Journal of molecular and cellular cardiology.

[99]  M. Bennett,et al.  Aging and Atherosclerosis: Mechanisms, Functional Consequences, and Potential Therapeutics for Cellular Senescence , 2012, Circulation research.

[100]  Yael H. Edrey,et al.  Sustained high levels of neuregulin‐1 in the longest‐lived rodents; a key determinant of rodent longevity , 2012, Aging cell.

[101]  B. Lopez,et al.  Oxidative stress induces an ATM‐independent senescence pathway through p38 MAPK‐mediated lamin B1 accumulation , 2012, The EMBO journal.

[102]  D. Levy,et al.  Telomeres, atherosclerosis, and the hemothelium: the longer view. , 2012, Annual review of medicine.

[103]  S. Tang,et al.  Omentin-1 attenuates arterial calcification and bone loss in osteoprotegerin-deficient mice by inhibition of RANKL expression. , 2011, Cardiovascular research.

[104]  P. Chatterjee,et al.  Pin1 Deficiency Causes Endothelial Dysfunction and Hypertension , 2011, Hypertension.

[105]  Mei Han,et al.  miR‐146a and Krüppel‐like factor 4 form a feedback loop to participate in vascular smooth muscle cell proliferation , 2011, EMBO reports.

[106]  Elliot L Elson,et al.  Short Communication: Vascular Smooth Muscle Cell Stiffness As a Mechanism for Increased Aortic Stiffness With Aging , 2010, Circulation research.

[107]  G. Mann,et al.  Enhanced neointimal hyperplasia and carotid artery remodelling in sequestosome 1 deficient mice , 2009, Journal of cellular and molecular medicine.

[108]  J. Parker,et al.  Functional Analysis of the Chromosome 9p21.3 Coronary Artery Disease Risk Locus , 2009, Arteriosclerosis, thrombosis, and vascular biology.

[109]  K. Andrews,et al.  Arginase II Knockout Mouse Displays a Hypertensive Phenotype Despite a Decreased Vasoconstrictory Profile , 2009, Hypertension.

[110]  J. Erusalimsky Vascular endothelial senescence: from mechanisms to pathophysiology. , 2009, Journal of applied physiology.

[111]  Judith Campisi,et al.  Senescence-Associated Secretory Phenotypes Reveal Cell-Nonautonomous Functions of Oncogenic RAS and the p53 Tumor Suppressor , 2008, PLoS biology.

[112]  Chunxiang Zhang,et al.  MicroRNA Expression Signature and Antisense-Mediated Depletion Reveal an Essential Role of MicroRNA in Vascular Neointimal Lesion Formation , 2007, Circulation research.

[113]  D. Baker,et al.  Aging-Associated Vascular Phenotype in Mutant Mice With Low Levels of BubR1 , 2007, Stroke.

[114]  K. Krause,et al.  The NOX family of ROS-generating NADPH oxidases: physiology and pathophysiology. , 2007, Physiological reviews.

[115]  M. Bennett,et al.  Vascular smooth muscle cell senescence in atherosclerosis. , 2006, Cardiovascular research.

[116]  B. Berk,et al.  Axl, A Receptor Tyrosine Kinase, Mediates Flow-Induced Vascular Remodeling , 2006, Circulation research.

[117]  M. Goligorsky,et al.  Premature senescence of endothelial cells: Methusaleh's dilemma. , 2006, American journal of physiology. Heart and circulatory physiology.

[118]  David Evans,et al.  Interleukin-1beta and signaling of interleukin-1 in vascular wall and circulating cells modulates the extent of neointima formation in mice. , 2006, The American journal of pathology.

[119]  Zhiyong Ma,et al.  Transcriptional Control of BubR1 by p53 and Suppression of Centrosome Amplification by BubR1 , 2005, Molecular and Cellular Biology.

[120]  R. Kumar,et al.  BubR1 insufficiency causes early onset of aging-associated phenotypes and infertility in mice , 2004, Nature Genetics.

[121]  T. Lüscher,et al.  Deletion of p66shc Gene Protects Against Age-Related Endothelial Dysfunction , 2003, Circulation.

[122]  S. Davidge,et al.  Endothelial-dependent vasodilation is reduced in mesenteric arteries from superoxide dismutase knockout mice. , 2003, Cardiovascular research.

[123]  S. Lowe,et al.  Rb-Mediated Heterochromatin Formation and Silencing of E2F Target Genes during Cellular Senescence , 2003, Cell.

[124]  Edward G Lakatta,et al.  Arterial and Cardiac Aging: Major Shareholders in Cardiovascular Disease Enterprises: Part III: Cellular and Molecular Clues to Heart and Arterial Aging , 2003, Circulation.

[125]  C Roskelley,et al.  A biomarker that identifies senescent human cells in culture and in aging skin in vivo. , 1995, Proceedings of the National Academy of Sciences of the United States of America.

[126]  L. Hayflick,et al.  The serial cultivation of human diploid cell strains. , 1961, Experimental cell research.